Author/Authors
Eryilmaz, Müjde Ankara Üniversitesi - Eczacilik Fakültesi - Farmasötik Mikrobiyoloji Anabilim Dalı, Turkey , Bozkurt, Merve Eylül Ankara Üniversitesi - Eczacilik Fakültesi - Farmasötik Mikrobiyoloji Anabilim Dalı, Turkey , Yildiz, Muharrem Murat Etlik Lokman Hekim Hastanesi, Turkey , Akin, Ahmet Ankara Üniversitesi - Eczacilik Fakültesi - Farmasötik Mikrobiyoloji Anabilim Dalı, Turkey
Title Of Article
Investigation of the prevalance of extended spectrum beta lactamase producing escherichia coli strains isolated from various clinical specimens
شماره ركورد
18681
Abstract
Infections caused by Escherichia coli (E.coli) producing extended-spectrum beta lactamase (ESBL) are important because they are difficult to treat, have high mortality rate and cause big economic losses. In this study, prevalence of ESBL production in 114 E.coli strains, isolated from various clinical specimens at Lokman Hekim Hospital between September 2008-April 2009 was observed. The production of ESBL was determined with double disc synergy test and phenotypic confirmation test according to the Clinical Laboratory Standards Institute (CLSI) guidelines. The prevalence of ESBL producing E.coli isolates was found to be 18,42%. The results of the studies on prevalence of ESBL positive E.coli strains will be helpful for using antimicrobials in empiric treatment.
From Page
10
NaturalLanguageKeyword
double disc synergy test , Escherichia coli , extended spectrum beta , lactamase
JournalTitle
Journal of Research in Pharmacy
To Page
12
JournalTitle
Journal of Research in Pharmacy
Link To Document